metricas
covid
Buscar en
Revista Española de Cirugía Ortopédica y Traumatología
Toda la web
Inicio Revista Española de Cirugía Ortopédica y Traumatología Less superior adjacent syndrome and lower reoperation rate. Medium- and long-te...
Journal Information

Statistics

Follow this link to access the full text of the article

Review article
Less superior adjacent syndrome and lower reoperation rate. Medium- and long-term results of cervical arthroplasty versus anterior cervical arthrodesis: Systematic review and meta-analysis of randomized clinical trials
Menor síndrome adyacente superior y menor tasa de reoperación. Resultados a mediano y a largo plazo de la artroplastia cervical frente a la artrodesis cervical anterior: revisión sistemática y metaanálisis de ensayos clínicos aleatorizados
J.H. Núñeza,b,
Corresponding author
hassan2803med@gmail.com

Corresponding author.
, B. Escuderoa, J.D. Montenegroa, M.J. Jiménez-Jiméneza, J. Martínez-Peñaa, M. Surrocaa, D. Bosch-Garcíaa,c
a Unidad de Columna Vertebral, Servicio de Traumatología y Cirugía Ortopédica, Hospital Universitario de Mutua Terrassa, Tarrasa (Barcelona), Spain
b Unidad de Columna, Artro-Esport, Centro Médico Teknon, Barcelona, Spain
c Grup Traumatologic de Catalunya, Barcelona, Spain
Read
566
Times
was read the article
111
Total PDF
455
Total HTML
Share statistics
Article information
ISSN: 18884415
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 December 30 0 30
2024 November 32 2 34
2024 October 38 2 40
2024 September 57 3 60
2024 August 50 2 52
2024 July 18 4 22
2024 June 30 15 45
2024 May 48 12 60
2024 April 59 9 68
2024 March 47 9 56
2024 February 8 5 13
2024 January 30 9 39
2023 December 5 25 30
2023 November 3 14 17
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos